Redcare Pharmacy NVSHPPF 65 PB Ratio is 2.50 as of Jun. 24, 2026, which is 38% below its 10-year median of 4.03. GuruFocus rates SHPPF with a GF Score™ of 65/100 and a GF Value™ of $179.18 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks worse than 69.89% on this metric.
The historical rank and industry rank for Redcare Pharmacy NV's PB Ratio or its related term are showing as below:
SHPPF'
s PB Ratio Range Over the Past 10 Years
Min: 1.35 Med: 4.03 Max: 32.77
Current: 3.01
During the past 13 years, Redcare Pharmacy NV's highest PB Ratio was 32.77. The lowest was 1.35. And the median was 4.03.
SHPPF's PB Ratio is ranked worse than 69.89% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs SHPPF: 3.01
During the past 12 months, Redcare Pharmacy NV's average Book Value Per Share Growth Rate was -5.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 0.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 27.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Redcare Pharmacy NV was 302.90% per year. The lowest was 1.60% per year. And the median was 7.50% per year.
Back to Basics: PB Ratio
Redcare Pharmacy NV (OTCPK:SHPPF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Redcare Pharmacy NV PB Ratio Related Terms
Redcare Pharmacy NV PB Ratio Historical Data
* Premium members only.
The historical data trend for Redcare Pharmacy NV's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redcare Pharmacy NV PB Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's PB Ratio distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Redcare Pharmacy NV (SHPPF) has a PB Ratio of 2.50 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Redcare Pharmacy NV and its competitors. This is 38% below median its historical median of 4.03. Over the past decade, Redcare Pharmacy NV's PB Ratio has ranged from 1.35 to 32.77. According to the industry distribution chart, Redcare Pharmacy NV ranks #427 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 69.9%.
Is Redcare Pharmacy NV's PB Ratio too high?
Redcare Pharmacy NV's current PB Ratio of 2.50 is 38% below median its 10-year median of 4.03. Over the past 10 years, this metric has ranged from a low of 1.35 to a high of 32.77. The Healthcare Providers & Services industry median PB Ratio is 1.96. Redcare Pharmacy NV's value of 2.50 is 27.6% above this industry median. Based on the distribution chart, Redcare Pharmacy NV ranks #427 out of 611 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #427 out of 611 companies for PB Ratio. This places Redcare Pharmacy NV in the lower half of its industry. The industry median PB Ratio is 1.96. Redcare Pharmacy NV's value of 2.50 is 27.6% above this benchmark. Historically, Redcare Pharmacy NV's own PB Ratio has ranged from 1.35 to 32.77 over the past decade. While the company's 10-year median is 4.03 vs. the industry median of 1.96, Redcare Pharmacy NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redcare Pharmacy NV's current PB Ratio of 2.50 is 27.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Redcare Pharmacy NV and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current PB Ratio is 2.50, which is 38% below median its own 10-year median of 4.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (SHPPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $179.18, compared to a current price of $64.80 — trading 63.8% below its estimated fair value. The current PB Ratio is 2.50, which is 38% below median its 10-year median of 4.03 and 27.6% above the Healthcare Providers & Services industry median of 1.96. Redcare Pharmacy NV's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Redcare Pharmacy NV (SHPPF), the current PB Ratio is 2.50 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (SHPPF) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of $64.80 is trading 63.8% below its estimated GF Value™ of $179.18.
GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.
Key valuation signals for SHPPF:
PB Ratio: 2.50 (38% below median its 10-year median of 4.03)
GF Value™: $179.18 vs. price of $64.80 (63.8% below fair value)
Industry Position: 27.6% above the Healthcare Providers & Services median (#427 of 611)
No single metric tells the full story. See the SHPPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
65GF Score
Get the complete analysis for SHPPF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPPF has been successfully added to your 
